N-acetyl-L-cysteine inhibits wear particle-induced prosthesis loosening

Journal of Surgical Research

Volumn 168, Issue 2, 2011, Pages

  Fang, Qing ^a   Wang, Huayi ^a   Zhu, Shu ^a   Zhu, Qingsheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

N acetyl L cysteine; osteoclastogenesis; osteolysis; PMMA; prosthesis loosening

Indexed keywords

ACETYLCYSTEINE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; PHOSPHATE BUFFERED SALINE; POLY(METHYL METHACRYLATE);

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MASS; BONE VOLUME FRACTION; CALVARIA; CELL COUNT; CELL LABELING; CONTROLLED STUDY; CORTICAL MEAN THICKNESS; CORTICAL TOTAL AREA; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; RAT;

ACETYLCYSTEINE; ANIMALS; ARTHROPLASTY, REPLACEMENT; CELLS, CULTURED; FREE RADICAL SCAVENGERS; MICE; OSTEOCLASTS; OSTEOLYSIS; POLYMETHYL METHACRYLATE; PROSTHESIS FAILURE; RATS; SKULL; X-RAY MICROTOMOGRAPHY;

EID: 79955794765     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.12.006     Document Type: Article

References (37)

1. Yamanaka Y, Abu-Amer W, Foglia D, et al. NFAT2 is an essential mediator of orthopedic particle-induced osteoclastogenesis. J Orthop Res 2008;26:1577.
2. Warashina H, Sakano S, Kitamura S, et al. Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria. Biomaterials 2003;24:3655.
3. Clohisy JC, Frazier E, Hirayama T, et al. RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res 2003;21:202.
4. Shardlow DL, Stone MH, Ingham E, et al. Cement particles containing radio-opacifiers stimulate pro-osteolytic cytokine production from a human monocytic cell line. J Bone Joint Surg Br 2003;85:900.
5. Perry MJ, Mortuza FY, Ponsford FM, et al. Properties of tissue from around cemented joint implants with erosive and/or linear osteolysis. J Arthroplasty 1997;12:670.
6. Stea S, Visentin M, Granchi D, et al. Cytokines and osteolysis around total hip prostheses. Cytokine 2000;12:1575.
7. Brooks RA, Wimhurst JA, Rushton N. Endotoxin contamination of particles produces misleading inflammatory cytokine responses from macrophages in vitro. J Bone Joint Surg Br 2002;84:295.
8. Clohisy JC, Teitelbaum S, Chen S, et al. Tumor necrosis factora mediates polymethylmethacrylate particle-induced NF-κB activation in osteoclast precursor cells. J Orthop Res 2002;20:174.
9. Soysa NS, Alles N. NF-κB functions in osteoclasts. Biochem Biophys Res Commun 2009;378:1.
10. Childs LM, Paschalis EP, Xing L, et al. In vivo RANK signaling blockade using the receptor activator of NF-κB: Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 2002;17:192.
11. Nakamura Y, Shimetani A, Fujii H, et al. Glutathione can efficiently prevent direct current-induced cytotoxicity. J Endod 2008;34:693.
12. Oka S, Kamata H, Kamata K, et al. N-acetylcysteine suppresses TNF-induced NF-κB activation through inhibition of IκB kinases. FEBS Lett 2000;472:196.
13. Barnes PJ, Karin M. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066.
14. Abbas S, Clohisy JC, Abu-Amer Y. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 2003;21:1041.
15. Ragab AA, Van De Motter R, Lavish SA, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999;17:803.
16. Chen JR, Shankar K, Nagarajan S, et al. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-κB ligand signaling cascade. J Pharmacol Exp Ther 2008;324:50.
17. Merkel KD, Erdmann JM, McHugh KP, et al. Tumor necrosis factor-a mediates orthopedic implant osteolysis. Am J Pathol 1999;154:203.
18. Schwarz EM, Benz EB, Lu AP, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000;18:849.
19. Childs LM, Goater JJ, O'Keefe RJ, et al. Effect of anti-tumor necrosis factor-α gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001;83-A:1789.
20. Masui T, Sakano S, Hasegawa Y, et al. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium- and polyethylene particles. Biomaterials 2005;26:1695.
21. Clohisy JC, Hirayama T, Frazier E, et al. NF-κB signaling blockade abolishes implant particle-induced osteoclastogenesis. J Orthop Res 2004;22:13.
22. Endo MM, Barbour PS, Barton DC, et al. Comparative wear and wear debris under three different counterface conditions of crosslinked and non-crosslinked ultra high molecular weight polyethylene. Biomed Mater Eng 2001;11:23.
23. Robertsson O, Wingstrand H, Kesteris U, et al. Intracapsular pressure and loosening of hip prostheses. Preoperative measurements in 18 hips. Acta Orthop Scand 1997;68:231.
24. Sochart DH, Porter ML. The long-term results of Charnley low-friction arthroplasty in young patients who have congenital dislocation, degenerative osteoarthrosis, or rheumatoid arthritis. J Bone Joint Surg Am 1997;79:1599.
25. Muratoglu OK, Bragdon CR, O'Connor DO, et al.A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. Recipient of the 1999 HAP Paul Award. J Arthroplasty 2001;16:149.
26. Maloney WJ, Smith RL, Schmalzried TP, et al. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am 1995;77:1301.
27. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am 1992;74:849.
28. Yamauchi K, Hasegawa Y, Iwasada S, et al. Head penetration into Hylamer acetabular liner sterilized by gamma irradiation in air and in a nitrogen atmosphere. J Arthroplasty 2001;16:463.
29. Redlich K, Hayer S, Ricci R, et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 2002;110:1419.
30. Franzoso G, Carlson L, Xing L, et al. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev 1997;11:3482.
31. Fahy BN, Schlieman MG, Mortenson MM, et al. Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol 2005;56:46.
32. Orlowski RZ, Baldwin AS Jr. NF-κB as a therapeutic target in cancer. Trends Mol Med 2002;8:385.
33. Richmond A. Nf-κ B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002;2:664.
34. Reelfs O, Tyrrell RM, Pourzand C. Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-κB in human skin fibroblasts. J Invest Dermatol 2004; 122:1440.
35. Viatour P, Bentires-Alj M, Chariot A, et al. NF-κB2/p100 induces Bcl-2 expression. Leukemia 2003;17:1349.
36. Yang J, Su Y, Richmond A. Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-κB pathway. Free Radic Biol Med 2007;42:1369.
37. Hefferan TE, Evans GL, Lotinun S, et al. Effect of gender on bone turnover in adult rats during simulated weightlessness. J Appl Physiol 2003;95:1775.